Castle Biosciences Inc. (CSTL) Reports Q4 EPS of $0.11

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q4 EPS of $0.11, versus $0.38 reported last year. Revenue for the quarter came in at $17.6 million, versus $11.44 million reported last year.

2020 Revenue Guidance:

Castle Biosciences anticipates generating $61-64 million in revenue in 2020.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc. (XP) Tops Q2 EPS by 8c
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance